Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP). Saldanha EF, Cordeiro de Lima VC, Fares A, Corassa M, et al. Oncologist 2025;30:oyae347.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saldanha EF, Cordeiro de Lima VC, Fares A, Corassa M, et al. Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP). Oncologist 2025;30:oyae347.
PMID: 40036771